home All News open_in_new Full Article

Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia

A review of recent findings suggests that Appili’s biodefense vaccine, ATI-1701, may have a role in preventing tularemia outbreaks HALIFAX, Nova Scotia, May 01, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced a publication in […]


today 9 h. ago attach_file Sport

attach_file Events
attach_file Society
attach_file Events
attach_file Other
attach_file Other
attach_file Sport
attach_file Sport
attach_file Other
attach_file Economics
attach_file Events
attach_file Economics
attach_file Other
attach_file Other
attach_file Events
attach_file Politics
attach_file Events
attach_file Culture
attach_file Society
attach_file Society
attach_file Other


ID: 3871671012
Add Watch Country

arrow_drop_down